KALA BIO, INC. Depreciation
KALA BIO, INC. (KALA) reported Depreciation of $216.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-04-15
- KALA BIO, INC. depreciation for the quarter ending 2020-12-31 was $234.00K, a 2.18% increase year-over-year.
- KALA BIO, INC. depreciation for the quarter ending 2020-09-30 was $220.00K, a 2.65% decline year-over-year.
- KALA BIO, INC. depreciation for the quarter ending 2020-06-30 was $224.00K, a 2.75% increase year-over-year.
- KALA BIO, INC. depreciation for the quarter ending 2020-03-31 was $230.00K, a 35.29% increase year-over-year.
- KALA BIO, INC. depreciation for fiscal 2025 was $216.00K, a 5.88% increase from fiscal 2024.
- KALA BIO, INC. depreciation for fiscal 2024 was $204.00K, a 17.74% decline from fiscal 2023.
- KALA BIO, INC. depreciation for fiscal 2023 was $248.00K, a 41.09% decline from fiscal 2022.
- KALA BIO, INC. depreciation for fiscal 2022 was $421.00K, a 54.88% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $216.00K 10-K · filed 2026-04-15 | |||
| 2024-12-31 | $204.00K 10-K · filed 2026-04-15 | |||
| 2023-12-31 | $248.00K 10-K · filed 2025-03-31 | |||
| 2022-12-31 | $421.00K 10-K · filed 2024-03-29 | |||
| 2021-12-31 | $933.00K 10-K · filed 2023-03-03 | |||
| 2020-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $454.00K derived: sum of 2 quarters · filed 2022-03-29 | $678.00K derived: sum of 3 quarters · filed 2022-03-29 | $908.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $444.00K derived: sum of 2 quarters · filed 2020-11-05 | $674.00K 10-Q · filed 2020-11-05 | $903.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $454.00K 10-Q · filed 2020-08-06 | $683.00K derived: sum of 3 quarters · filed 2021-02-25 | $909.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-03-31 | $230.00K 10-Q · filed 2020-05-07 | $459.00K derived: sum of 2 quarters · filed 2021-02-25 | $685.00K derived: sum of 3 quarters · filed 2021-02-25 | $903.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $455.00K derived: sum of 2 quarters · filed 2021-02-25 | $673.00K derived: sum of 3 quarters · filed 2021-02-25 | $843.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $444.00K derived: sum of 2 quarters · filed 2020-11-05 | $614.00K 10-Q · filed 2020-11-05 | $723.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $218.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $388.00K 10-Q · filed 2020-08-06 | $497.00K derived: sum of 3 quarters · filed 2020-08-06 | $567.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $170.00K 10-Q · filed 2020-05-07 | $279.00K derived: sum of 2 quarters · filed 2020-05-07 | $349.00K derived: sum of 3 quarters · filed 2020-05-07 | $441.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $179.00K derived: sum of 2 quarters · filed 2020-02-12 | $271.00K derived: sum of 3 quarters · filed 2020-02-12 | $352.00K 10-K · filed 2020-02-12 |
| 2018-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $162.00K derived: sum of 2 quarters · filed 2019-11-07 | $243.00K 10-Q · filed 2019-11-07 | $317.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $173.00K 10-Q · filed 2019-08-06 | $247.00K derived: sum of 3 quarters · filed 2019-08-06 | $320.00K derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $81.00K 10-Q · filed 2019-05-09 | $155.00K derived: sum of 2 quarters · filed 2019-05-09 | $228.00K derived: sum of 3 quarters · filed 2019-05-09 | $299.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $147.00K derived: sum of 2 quarters · filed 2019-03-12 | $218.00K derived: sum of 3 quarters · filed 2019-03-12 | $287.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $144.00K derived: sum of 2 quarters · filed 2018-11-08 | $213.00K 10-Q · filed 2018-11-08 | $290.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $140.00K 10-Q · filed 2018-08-09 | $217.00K derived: sum of 3 quarters · filed 2018-08-09 | $290.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $69.00K 10-Q · filed 2018-05-10 | $146.00K derived: sum of 2 quarters · filed 2018-05-10 | $219.00K derived: sum of 3 quarters · filed 2018-05-10 | |
| 2016-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $150.00K derived: sum of 2 quarters · filed 2018-04-02 | $297.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $220.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $147.00K 10-Q · filed 2017-08-31 | |||
| 2015-12-31 | $330.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |